These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34378859)

  • 1. Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management.
    Shibata S; Uchida S
    Ther Apher Dial; 2022 Feb; 26(1):3-14. PubMed ID: 34378859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic renal disease progression: treatment strategies and potassium intake.
    Sinha AD; Agarwal R
    Semin Nephrol; 2013 May; 33(3):290-9. PubMed ID: 23953806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Hyperkalemia: An Update for the Internist.
    Kovesdy CP
    Am J Med; 2015 Dec; 128(12):1281-7. PubMed ID: 26093176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis.
    Palmer BF
    Mayo Clin Proc; 2020 Feb; 95(2):339-354. PubMed ID: 31668450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Hyperkalemia in End Stage Renal Disease.
    Akbar SR; Ahmed US; Iqbal HI
    W V Med J; 2016; 112(6):34-8. PubMed ID: 29368827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperkalemia in the Hypertensive Patient.
    Lakkis JI; Weir MR
    Curr Cardiol Rep; 2018 Mar; 20(2):12. PubMed ID: 29492706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperkalemia: Inpatient PaniK.
    Yee J
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):267-271. PubMed ID: 29031351
    [No Abstract]   [Full Text] [Related]  

  • 8. Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
    Tandukar S; Fried LF
    Nephron; 2018; 140(1):58-62. PubMed ID: 29972830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease].
    Degli Esposti L; Perrone V; Giacomini E; Sangiorgi D; Alessandrini D; Santoro A
    G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Hyperkalemia: Another Benefit of Exercise in People With Chronic Kidney Disease?
    St-Jules DE; Marinaro M; Goldfarb DS; Byham-Gray LD; Wilund KR
    J Ren Nutr; 2020 Sep; 30(5):380-383. PubMed ID: 31767517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative hyperkalemia in hemodialysis patients undergoing parathyroidectomy for renal hyperparathyroidism.
    Yang G; Wang J; Sun J; Zha X; Wang N; Xing C
    Intern Emerg Med; 2019 Oct; 14(7):1065-1071. PubMed ID: 30648222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of angiotensin converting enzyme inhibitors on potassium homeostasis in dialysis patients with and without residual renal function.
    Garthwaite E; Bhandari S
    Artif Organs; 2009 Aug; 33(8):641-7. PubMed ID: 19624582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?
    Ramos CI; González-Ortiz A; Espinosa-Cuevas A; Avesani CM; Carrero JJ; Cuppari L
    Nephrol Dial Transplant; 2021 Nov; 36(11):2049-2057. PubMed ID: 33247727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia.
    Pirklbauer M
    Hemodial Int; 2020 Jul; 24(3):282-289. PubMed ID: 32436307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Potassium Homeostasis in CKD.
    DuBose TD
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):305-314. PubMed ID: 29031357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hyperkalemia: 2.0 version].
    Blanc C; Martin PY
    Rev Med Suisse; 2018 Feb; 14(595):406-410. PubMed ID: 29465871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in treatment of hyperkalemia in chronic kidney disease.
    Sarafidis PA; Georgianos PI; Bakris GL
    Expert Opin Pharmacother; 2015; 16(14):2205-15. PubMed ID: 26330193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights Into Dietary Approaches to Potassium Management in Chronic Kidney Disease.
    Sumida K; Biruete A; Kistler BM; Khor BH; Ebrahim Z; Giannini R; Sussman-Dabach EJ; Avesani CM; Chan M; Lambert K; Yee-Moon Wang A; Clegg DJ; Burrowes JD; Palmer BF; Carrero JJ; Kovesdy CP
    J Ren Nutr; 2023 Nov; 33(6S):S6-S12. PubMed ID: 37610407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia].
    Hannedouche T; Fouque D; Joly D
    Nephrol Ther; 2018 Nov; 14(6S):6S17-6S25. PubMed ID: 30473062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.